{
  "paper_metadata": {
    "pmid": "12698193",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from the study."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6503delTT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 48,
        "demographics": "Not specified",
        "phenotype": "Breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 48,
        "affected_count": 27,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 56.25,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The BRCA2 6503 delTT mutation is a recognized founder mutation, distributed throughout Europe and the USA.",
        "assays": []
      },
      "segregation_data": "Yes, it segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on multiple family cases.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This mutation is particularly frequent among families attending the Aberdeen and Dundee clinics.",
      "key_quotes": [
        "The BRCA2 6503 delTT mutation is relatively frequent among families attending the Aberdeen and Dundee clinics."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9877-67del4",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "Not specified",
        "phenotype": "Not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is believed to affect splicing.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "Moderate evidence based on its effect on splicing.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Details on affected individuals are not provided.",
      "key_quotes": []
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Breast and ovarian cancers recorded in BRCA1 and BRCA2 mutation-bearing families",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted, with a focus on penetrance data."
  }
}